Literature DB >> 592853

Squamous cell carcinoma of the esophagus: a study of 153 cases.

H Takita, R G Vincent, V Caicedo, A C Gutierrez.   

Abstract

The incidence of esophageal carcinoma in the United States is relatively low; total estimated cases annually are about 7,000 (Ca, 1975). The overall cure rate, however, is about the worst among all malignant diseases and is reported to be 3% (Ca, 1975). We reviewed cases of squamous cell carcinoma of the esophagus treated at Roswell Park Memorial Institute to understand the clinicopathologic features in order to improve our therapeutic results.

Entities:  

Mesh:

Year:  1977        PMID: 592853     DOI: 10.1002/jso.2930090604

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Factors contributing to deficiencies in cell-mediated immunity in esophageal cancer patients.

Authors:  T Saito; A Kuwahara; K Shimoda; T Kinoshita; A Nakamura; M Miyahara; M Kobayashi
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

2.  Increases in immunoglobulin and complement in patients with esophageal or gastric cancer.

Authors:  T Saito; A Kuwahara; T Kinoshita; Y Shigemitsu; K Shimoda; M Miyahara; M Kobayashi
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

3.  Factors influencing the acute phase protein levels in patients with esophageal cancer.

Authors:  T Saito; A Kuwahara; K Shimoda; T Kinoshita; K Sato; M Miyahara; M Kobayashi
Journal:  Jpn J Surg       Date:  1991-07

4.  Panendoscopy as a screening procedure for simultaneous primary tumors in head and neck cancer.

Authors:  I J Dhooge; M De Vos; F W Albers; P B Van Cauwenberge
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

5.  The unrewarding results of curative therapy in esophageal cancer.

Authors:  W A Bethune; P P Kumar
Journal:  J Natl Med Assoc       Date:  1979-09       Impact factor: 1.798

6.  Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.

Authors:  Yen-Hao Chen; Hung-I Lu; Chih-Yen Chien; Chien-Ming Lo; Yu-Ming Wang; Shang-Yu Chou; Yan-Ye Su; Li-Hsueh Shih; Shau-Hsuan Li
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

7.  Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.

Authors:  Yen-Hao Chen; Hung-I Lu; Chih-Yen Chien; Chien-Ming Lo; Yu-Ming Wang; Shang-Yu Chou; Shau-Hsuan Li
Journal:  J Clin Med       Date:  2020-01-10       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.